 | Up a level |
2015
Hentrich, M., Schommers, P., Gillor, D., Mueller, M., Stoehr, A., Schultze, A., Jensen, B., Wasmuth, J. -C., Wolf, T., Siehl, J., Oette, M., Taylor, N., Zinngrebe, B., Hensel, M., Horst, H. -A., Faetkenheuer, G., Wyen, C. and Hoffmann, C. (2015). Lymphoma-associated mortality in the German HIV-lymphoma cohort study. Oncol. Res. Treat., 38. S. 198 - 199. BASEL: KARGER. ISSN 2296-5262
Hoffmann, C., Hentrich, M., Gillor, D., Behrens, G., Jensen, B., Stoehr, A., Esser, S., van Lunzen, J., Krznaric, I., Mueller, M., Oette, M., Hensel, M., Thoden, J., Faetkenheuer, G. and Wyen, C. (2015). Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study. HIV Med., 16 (4). S. 261 - 265. HOBOKEN: WILEY-BLACKWELL. ISSN 1468-1293
Hoffmann, C., Hentrich, M., Gillor, D., Behrens, G., Jensen, B., Stoehr, A., Esser, S., van Lunzen, J., Krznaric, I., Mueller, M., Oette, M., Hensel, M., Thoden, J., Faetkenheuer, G. and Wyen, C. (2015). Hodgkin lymphoma is as common as non-Hodgkin lymphoma in HIV-positive patients with sustained viral suppression and limited immune deficiency: a prospective cohort study. HIV Med., 16 (4). S. 261 - 265. HOBOKEN: WILEY-BLACKWELL. ISSN 1468-1293
2014
Sellner, L., Oles, M., Anders, S., Zapatka, M., Lukas, M., Slabicki, M., Blume, C., Huellein, J., Stolz, T., Muley, C., Sill, M., Oakes, C. C., Dietrich, S., Merkel, O., Jauch, A., Schrader, A., Hensel, M., Rossi, D., Zirlik, K., Herling, M., Nguyen-Khac, F., Seiffert, M., Dreger, P., von Kalle, C., Ho, A. D., Glimm, H., Duerig, J., Ringshausen, I., Huber, W. and Zenz, T. (2014). SYSTEMATIC DRUG SENSITIVITY SCREENING IN LYMPHOID MALIGNANCIES IDENTIFIES VULNERABILITIES OF CHRONIC LYMPHOCYTIC LEUKEMIA WITH HIGH RISK ABERRATIONS. Haematologica, 99. S. 316 - 317. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078
2010
Hallek, M., Fischer, K., Fingerle-Rowson, G., Fink, A. M., Busch, R., Mayer, J., Hensel, M., Hopfinger, G., Hess, G., von Gruenhagen, U., Bergmann, M., Catalano, J., Zinzani, P. L., Caligaris-Cappio, F., Seymour, J. F., Berrebi, A., Jaeger, U., Cazin, B., Trneny, M., Westermann, A., Wendtner, C. M., Eichhorst, B. F., Staib, P., Buehler, A., Winkler, D., Zenz, T., Boettcher, S., Ritgen, M., Mendila, M., Kneba, M., Doehner, H. and Stilgenbauer, S. (2010). Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet, 376 (9747). S. 1164 - 1175. NEW YORK: ELSEVIER SCIENCE INC. ISSN 0140-6736